심장 수술에서 맞춤형 간호와 노쇠 결과
심장 수술을 받는 허약 환자에서 표적 맞춤형 간호 중재가 허약 수준과 임상 결과에 미치는 영향: 무작위 대조 시험
This study is a randomized controlled trial aiming to compare targeted individualized nursing care with standard care in frail elderly patients undergoing cardiac surgery.
The hypotheses of the study are:
H1: Targeted individualized nursing care has an effect on the frailty level of frail elderly patients undergoing cardiac surgery.
H2: Targeted individualized nursing care affects the factors influencing frailty in frail elderly patients undergoing cardiac surgery.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Eskişehir, 터키 (Türkiye)
- Eskişehir Osmangazi University Health, Practice, and Research Hospital
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Aged 65 years and older
- Scheduled for elective surgery
- Edmonton Frail Scale score ≥ 7
- Able to speak Turkish and communicate effectively
- Can be transferred from the postoperative intensive care unit to the ward
- Patients who agree to participate in the study
Exclusion Criteria:
- Patients with neurological or psychological disorders
- Patients who cannot be transferred from the postoperative intensive care unit to the ward
- Emergency and unplanned cases
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
간섭 없음: Control group
Standard nursing care was provided to patients in this group |
|
|
실험적: Targeted Individualized Nursing Care Group
An individualized nursing intervention targeting risk factors associated with frailty was planned for patients in this group |
Targeted Individualized Nursing Care |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Cognitive Function - Standardized Mini-Mental State Examination (MMSE)
기간: Postoperative day 1 and the day of discharge
|
Cognitive status will be assessed using the Standardized Mini-Mental State Examination (MMSE). The MMSE evaluates orientation, memory, attention, recall, language, and visuospatial skills. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. Scores of 23 or below are generally considered indicative of cognitive impairment. |
Postoperative day 1 and the day of discharge
|
|
Cognitive Function - Delirium Risk - Nursing Delirium Screening Scale (Nu-DESC)
기간: Postoperative day 1 and the day of discharge
|
Delirium risk will be evaluated using the Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five domains: disorientation, inappropriate behavior, inappropriate communication, hallucinations, and psychomotor retardation. Each symptom is scored per shift as follows: 0 points: Symptom absent, 1 point: Symptom present/mild, 2 points: Symptom present and pronounced/severe A total score of 2 points or higher is considered indicative of delirium. |
Postoperative day 1 and the day of discharge
|
|
Physical Status Assessment - Pain Level - Numeric Rating Scale (NRS)
기간: Postoperative day 1 and the day of discharge
|
Pain Level - Numeric Rating Scale (NRS): Pain intensity will be assessed using the Numeric Rating Scale (NRS). Patients rate their pain from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. |
Postoperative day 1 and the day of discharge
|
|
Physical Status Assessment - Katz Activities of Daily Living (ADL) Scale
기간: Postoperative day 1 and the day of discharge
|
Katz Activities of Daily Living (ADL) Scale: Functional status will be evaluated using the Katz Activities of Daily Living (ADL) Scale, which assesses independence in six activities: bathing, dressing, toileting, transferring, continence, and feeding. Higher scores indicate greater independence in daily activities. Evaluation of the scale is based on the total score obtained from these items: 0-6 points: Dependent, 7-12 points: Partially dependent, 13-18 points: Independent. |
Postoperative day 1 and the day of discharge
|
|
Physical Status Assessment - Itaki Fall Risk Scale
기간: Postoperative day 1 and the day of discharge
|
Itaki Fall Risk Scale: The Itaki Fall Risk Scale will be used to evaluate patients' risk of falling. The scale assesses various risk factors related to falls in hospitalized patients. The scale consists of 19 risk factors that may contribute to patient falls. The risk factors are categorized as major and minor, with 1 point assigned for each minor risk factor and 5 points for each major risk factor. Based on the total score obtained from evaluating all risk factors, two risk levels are defined: 0-4 points: Low risk, 5 points and above: High risk. |
Postoperative day 1 and the day of discharge
|
|
Nutritional Status - Mini Nutritional Assessment Short Form (MNA-SF)
기간: Postoperative day 1 and the day of discharge
|
Mini Nutritional Assessment Short Form (MNA-SF): Nutritional status will be assessed using the Mini Nutritional Assessment-Short Form (MNA-SF). The total score ranges from 0 to 14, with higher scores indicating better nutritional status. |
Postoperative day 1 and the day of discharge
|
|
Psychological Status Assessment - Geriatric Depression Scale (GDS)
기간: Postoperative day 1 and the day of discharge
|
Geriatric Depression Scale-15 (Short Form): It is a scale used to screen for depression in older adults. The total score ranges from 0 to 15. Scores of 0-4 indicate no depression, 5-8 indicate mild depression, 9-11 indicate moderate depression, and 12-15 indicate severe depression. |
Postoperative day 1 and the day of discharge
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- Decision Number: 33
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .